Abstract

Potential Therapeutic Agent In Psychiatric And Neurological Diseases: Alpha Lipoic Acid

Alpha lipoic acid (ALA) which is known by its antioxidant properties can lead to positive reflections through various mechanisms of action in nervous system diseases. ALA can create privileges in the treatment of neurological and psychiatric diseases through the vital features such as prevention of formation of reactive oxygen species (ROS), having a mission as a cofactor in various enzyme complexes, promotion the level of antioxidants and neurotransmitters in brain. It has also been shown to be responsible for regulation the nerve growth factor, prevention of neuronal damage and neuronal loss, and vitalization of damaged tissues. Hence, the implementation of ALA as a therapeutic substance in the therapy of neurological and psychiatric diseases is promising in the treatment of diseases. Finally, ALA can prevent diseases related with nervous system.


Author(s):

Hande Çekici and Yunus Emre Bakırhan



Abstract | Full-Text | PDF

Share this  Facebook  Twitter  LinkedIn  Google+

Recommended Conferences

  • Advances in Neurology and Neuropsychiatry
    August 27-28, 2018 Tokyo, Japan
  • Psychiatry & Mental Health
    September 14-15, 2018 Singapore
  • Advances and Innovations in Dementia
    September 17-18, 2018 Singapore
  • Neurology and Cognitive Neuroscience
    October 18-19, 2018 Warsaw, Poland
  • Depression, Anxiety and Stress Management
    November 05-06, 2018 Bangkok, Thailand
  • Bipolar Disorder: Psychiatry and Mental Health
    November 5-7, 2018 Abu Dhabi, UAE
Flyer image

Abstracted/Indexed in

  • Index Copernicus
  • Google Scholar
  • CiteFactor
  • Electronic Journals Library
  • Directory of Research Journal Indexing (DRJI)
  • WorldCat
  • Publons
  • Serials Union Catalogue (SUNCAT)
  • Geneva Foundation for Medical Education and Research